We are developing a novel immunotherapy for pancreatic cancer

Our mission is to develop a rational & effective combination immunotherapy for the deadly pancreatic cancer with
“natural and synthetic antigens” and working “immunopotentiators”.

Please contact us

If you are interested in the treatment
If you wish to collaborate
If you can help with funding our research

Working with Singapore partners to execute pre-clinical and clinical trials.